This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sherwin-Williams' (SHW) Q1 Earnings & Sales Lag Estimates
by Zacks Equity Research
Consolidated net sales of Sherwin-Williams (SHW) decline mainly due to a decrease in volumes in the Consumer Brands Group and the Performance Coatings Group in North America in Q1.
Ecolab (ECL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Atmos Energy, Ecolab and The Sherwin-Williams
by Zacks Equity Research
Atmos Energy, Ecolab and The Sherwin-Williams are part of the Zacks top Analyst Blog.
3 Dividend Aristocrats to Take the Edge off Market Volatility
by Tirthankar Chakraborty
With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.
Play Disaster Recovery Stocks on Earth Day
by Sanghamitra Saha
Global warming has been wreaking havoc on earth and causing natural disasters. Hence, these disaster recovery stocks could be prudent investing options on Earth Day.
Cabot (CBT) Chosen for $5M DOE Grant to Aid Hydrogen Economy
by Zacks Equity Research
Cabot (CBT) and its partners will utilize this money to help the implementation of fuel cells, which generate electricity by emitting only water.
Reasons Why You Should Retain Masimo (MASI) Stock for Now
by Zacks Equity Research
Masimo's (MASI) R&D activities raise optimism about the stock.
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
by Zacks Equity Research
CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
by Zacks Equity Research
Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
Why You Should Add Inspire Medical (INSP) to Your Portfolio
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Will Materials ETFs Gain Further as Q1 Earnings Unfold?
by Sweta Killa
Going into the Q1 earnings season, earnings releases from the sector giants will determine the movement of these funds.
CF Industries (CF), JERA Execute Joint Development Agreement
by Zacks Equity Research
CF Industries (CF) looks forward to collaborating closely with JERA and other stakeholders in Japan.
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
by Zacks Equity Research
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
VALE's Q1 Iron Ore & Copper Output Increase Y/Y, Nickel Lags
by Zacks Equity Research
VALE delivers first-quarter iron ore production of around 71 million tons (MT) and reiterates its 2024 iron ore production goal between 310 MT and 320 MT.
International Paper (IP) Inks Deal to Buy DS Smith for $7.4Bn
by Zacks Equity Research
International Paper (IP) confirms that it has entered into a deal to acquire DS Smith, a move that will create a global leader in sustainable packaging solutions.
Barrick (GOLD) Reports Lower Preliminary Production for Q1
by Zacks Equity Research
Barrick's (GOLD) preliminary Q1 gold production is lower sequentially, primarily due to mine sequencing at many locations and planned maintenance at Nevada Gold Mines.
Piedmont Lithium's (PLL) Project Gets Mining Permit Approval
by Zacks Equity Research
Piedmont Lithium (PLL) gets North Carolina mining permit approval for its Carolina Lithium project.
Air Products (APD) Gets Funds for Hydrogen Refueling Stations
by Zacks Equity Research
The two new stations will be built near Air Products' (APD) current German headquarters in Hattingen, where the company has been in operation for more than 60 years.
Koppers (KOP) Concludes Repricing & Upsizing of Term Loan B
by Zacks Equity Research
Reducing borrowings under its revolving credit facility is Koppers' (KOP) goal, including the recent borrowings used to finance the purchase of Brown Wood Preserving.
ATI Announces Completion of Vandergrift Operations Expansion
by Zacks Equity Research
This enhancement increases the capability of ATI's Specialty Rolled Products division.
Air Liquide (AIQUY) Expands Biomethane Production in U.S.
by Zacks Equity Research
Air Liquide (AIQUY) expands U.S. biomethane production with two new units, promoting a circular economy and supporting decarbonization efforts.
QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing
by Zacks Equity Research
QuidelOrtho's (QDEL) addition of the Fentanyl Test is likely to deliver rapid drugs-of-abuse detection amidst the escalating opioid crisis.
Eldorado Gold (EGO) Updates on Q1 Tax Impacts in Turkiye
by Zacks Equity Research
Eldorado Gold (EGO) updates on the tax impacts in Turkiye related to the weakening of the Turkish Lira in the first quarter of 2024.
DOW Boosts Automotive Partnerships in Europe With New Studio
by Zacks Equity Research
DOW's new studio will allow it to further collaborate with Tiers and OEMs, expanding its existing novel solutions.
Orion (OEC) Breaks Ground on Texas Battery Materials Plant
by Zacks Equity Research
Orion's (OEC) facility in La Porte is similar to one located in Berre-l'Etang, southern France.